Mr. Ron Andrews joins Precipio's Board of Directors
(NASDAQ:PRPO) announces that Mr. Ron Andrews has joined the company's Board of Directors. As the company continues to build its products division around commercializing the technologies it has developed (such as HemeScreen and IV-cell), having additional resources and experienced industry veterans to support management's goals is key to its success and ongoing growth. Mr. Andrews brings a wealth of experience in the diagnostics world, and specifically in the areas of product development & commercialization. Some of Mr. Andrews' past experiences includes Chief Commercial Officer at Roche Molec...
Source: benzinga.com